Viewing Study NCT00354068


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2026-02-22 @ 6:46 PM
Study NCT ID: NCT00354068
Status: COMPLETED
Last Update Posted: 2013-03-28
First Post: 2006-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
Sponsor: Duke University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module